3D cell culture 274
3D-CRT 247
Aftercare 10
AJCC 234
Anaplastic large cell lymphoma 302
Anatomical plane 386
Angiotensin converting enzyme 2 112
Attitude 116
Augmentation 308
Beckwith-Wiedemann syndrome 288
Belief 116
Benign breast disease 15, 239
Biomarkers 42, 234
Bone marrow transplantation 292
BRAIN metastases 62
BRCA 123
BRCA1/2 137
Breast 36, 80, 112, 165, 292, 297, 308, 321, 328, 341
Breast cancer 1, 15, 21, 28, 42, 62, 84, 86, 95, 116, 123, 128, 145, 180, 188, 206, 214, 234, 253, 265, 274, 302, 333, 325, 356, 371, 378
Breast cancer risk 150
Breast cancer surgery 302
Breast carcinoma 103
Breast disease 165, 239
Breast imaging 206, 234, 265, 363
Breast metastasis 200
Breast neoplasm 53, 258, 200, 220, 363
Breast reconstruction 21, 206, 386
Breast reduction 157
Breast sarcoma 292
Breast tumor 76, 197
Breast ultrasound 200
Breast volume 315
Breast-conserving surgery 220, 356, 363
Burkitt lymphoma 76
Cancer 297
Cancer staging 234
Cancer-associated fibroblast 341
Cardiac toxicity 145
Cardiothoracic 383
Cerebrospinal fluid 371
Chemotherapy 84, 356
Chest wall 383
Clinical practices 188
Core biopsy 258
Coronavirus 112
Cosmetic 308
Cost 297
COVID-19 112, 188, 173, 253
CT 173
Delay 180
Dendritic pattern 173
Desmoid type fibromatosis 197
Diagnostic imaging 328
Diffuse glandular pattern 173
Discomfort Intolerance Scale 68
Dissection 356
Doxorubicin 274
DS-GPA score 62
Early peak 253
Estradiol 150
Family history 137
Fibroepithelial breast tumors 288
Fibroepithelial lesion 36
Fibromatosis 197
Fine needle aspiration cytology 103
FZD9 42
Galectin-3 341
Garanuloma 383
Gene expression 112
Gigantomastia 76
Global health 86
Grade 123
Granulomatous mastitis 239
Gray zone 103
Gynecomastia 103, 173
Hamartoma 328
Health promotion 333
HER2 FISH study 128
Hereditary cancer 137
Hormone replacement therapy 150
Idiopathic granulomatous mastitis 239, 283
Image-guided biopsy 1
IMRT 247
In silico analysis 42
Indocyanine green 352
Innovation 86
Invasive breast cancer 341
Leptomeningal carcinomatosis 371
Liposome 274
Local neoplasm recurrence 10
Lung cancer 200
Lymph nodes 356
Lymphangiosarcoma 384
Lymphedema 378
Lymphovascular invasion 123
Magnetic resonance 1, 53, 197
Magnetic resonance imaging 371
Male breast 103, 173
Mammography 53, 68, 180, 315
Margings of excision 363
Masculine 333
Mastectomy 356, 386
Mastopexy 206
Men’s health 333
Metastasis 371
Metastatic breast cancer 328
Microbubble 274
Micropapillary carcinoma 341
Molecular subtypes 53
MRI 265
Multicentric 28
Multifocal 28
Myeloid sarcoma 292
Neoadjuvant chemotherapy 128, 180
Neutrophil-to-lymphocyte ratio 328
Nipple-areola complex 265
Nodular pattern 173
Oncoplastic surgery 220
Organs at risk 247
Pain 68
Pandemic 188
Papillary neoplasm 258
Pellet 150
Perception 95
Personality 308
Phyllodes tumor 10, 36, 80
PMRT 247
Polysomy 17 128
Post-mastectomy radiation 21
Pregnant women 283
Primary tumor resction 328
Prognostic factors 62
Proliferative breast lesion with atypia or without atypia 15
Quality 86, 297
Radiation dose 315
Radioisotopes 214
Radionuclide therapy 214
Radiopharmaceuticals 214
Radiotherapy 84, 145, 247
Re-excision 363
Reconstruction 386
Reliability 95
Rupture 383
SARS-CoV-2 188
Satellite 28
Screening 116
Sentinel lymph node biopsy 352
Severe acute respiratory syndrome coronavirus 2 112
Silicone breast implant 383
Steroid injection 283
Stewart-Treves syndrome 378
Superior pedicle; inferior pedicle 157
Superomedial pedicle 157
Surgery 80, 84, 328, 352, 369, 386
Survey 21, 188
Survival 328
Survival outcome 62
Testosterone pellet implantation 150
Tissue expander 21
Topical steroid 283
Triple-negative 123
Triple-negative breast cancer 42, 137
Tubular carcinoma 80
Tumor size 53
Tumorigenesis 288
Ultrasonography 1, 28, 53, 165
Ultrasound 197
Validity 95
Value 86, 297
Women 116, 296
